EA200100801A1 - THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING - Google Patents
THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDINGInfo
- Publication number
- EA200100801A1 EA200100801A1 EA200100801A EA200100801A EA200100801A1 EA 200100801 A1 EA200100801 A1 EA 200100801A1 EA 200100801 A EA200100801 A EA 200100801A EA 200100801 A EA200100801 A EA 200100801A EA 200100801 A1 EA200100801 A1 EA 200100801A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- manufacture
- treatment
- pharmaceutical composition
- nazal
- uterine bleeding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к применению полового гормона при изготовлении фармацевтической композиции, пригодной для назального введения и предназначенной для лечения нежелательных маточных кровотечений у женщин.Отчет о международном поиске был опубликован 2001.04.26.The present invention relates to the use of sex hormone in the manufacture of a pharmaceutical composition suitable for nasal administration and intended for the treatment of unwanted uterine bleeding in women. The international search report was published 2001.04.26.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9904022A FR2791572A1 (en) | 1999-03-31 | 1999-03-31 | Treating undesirable uterine bleeding, e.g. as side-effect of hormone therapy, by intranasal administration of estradiol |
PCT/FR2000/000790 WO2000059447A2 (en) | 1999-03-31 | 2000-03-30 | Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200100801A1 true EA200100801A1 (en) | 2002-04-25 |
Family
ID=9543854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200100801A EA200100801A1 (en) | 1999-03-31 | 2000-03-30 | THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1143978A2 (en) |
JP (1) | JP2002541076A (en) |
KR (1) | KR20010102464A (en) |
CN (1) | CN1346273A (en) |
AU (1) | AU3662300A (en) |
BR (1) | BR0008577A (en) |
CA (1) | CA2361885A1 (en) |
EA (1) | EA200100801A1 (en) |
FR (1) | FR2791572A1 (en) |
HK (1) | HK1044486A1 (en) |
HU (1) | HUP0200244A3 (en) |
NO (1) | NO20014022L (en) |
NZ (1) | NZ513672A (en) |
PL (1) | PL356767A1 (en) |
WO (1) | WO2000059447A2 (en) |
ZA (1) | ZA200106689B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4383993A (en) * | 1980-05-30 | 1983-05-17 | University Of Kentucky Research Foundation | Nasal dosage forms containing natural female sex hormones |
NL8801670A (en) * | 1988-07-01 | 1990-02-01 | Walter Adrianus Josephus Johan | PHARMACEUTICAL PREPARATION. |
US5922699A (en) * | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
ES2273374T3 (en) * | 1996-07-23 | 2007-05-01 | Pherin Pharmaceuticals, Inc. | STEROIDS AS UFO NEUROCHEMICAL STIMULATORS TO RELIEF PMS SYMPTOMS. |
-
1999
- 1999-03-31 FR FR9904022A patent/FR2791572A1/en not_active Withdrawn
-
2000
- 2000-03-30 CA CA002361885A patent/CA2361885A1/en not_active Abandoned
- 2000-03-30 NZ NZ513672A patent/NZ513672A/en not_active Application Discontinuation
- 2000-03-30 AU AU36623/00A patent/AU3662300A/en not_active Abandoned
- 2000-03-30 CN CN00804471A patent/CN1346273A/en active Pending
- 2000-03-30 HU HU0200244A patent/HUP0200244A3/en unknown
- 2000-03-30 EA EA200100801A patent/EA200100801A1/en unknown
- 2000-03-30 WO PCT/FR2000/000790 patent/WO2000059447A2/en not_active Application Discontinuation
- 2000-03-30 JP JP2000609012A patent/JP2002541076A/en active Pending
- 2000-03-30 BR BR0008577-4A patent/BR0008577A/en not_active IP Right Cessation
- 2000-03-30 PL PL00356767A patent/PL356767A1/en not_active Application Discontinuation
- 2000-03-30 KR KR1020017011124A patent/KR20010102464A/en not_active Application Discontinuation
- 2000-03-30 EP EP00915247A patent/EP1143978A2/en not_active Withdrawn
-
2001
- 2001-08-14 ZA ZA200106689A patent/ZA200106689B/en unknown
- 2001-08-17 NO NO20014022A patent/NO20014022L/en not_active Application Discontinuation
-
2002
- 2002-08-23 HK HK02106208.3A patent/HK1044486A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000059447A2 (en) | 2000-10-12 |
AU3662300A (en) | 2000-10-23 |
HK1044486A1 (en) | 2002-10-25 |
PL356767A1 (en) | 2004-07-12 |
NO20014022D0 (en) | 2001-08-17 |
NO20014022L (en) | 2001-08-17 |
HUP0200244A2 (en) | 2002-07-29 |
JP2002541076A (en) | 2002-12-03 |
EP1143978A2 (en) | 2001-10-17 |
ZA200106689B (en) | 2002-11-14 |
NZ513672A (en) | 2001-09-28 |
KR20010102464A (en) | 2001-11-15 |
WO2000059447A3 (en) | 2001-04-26 |
FR2791572A1 (en) | 2000-10-06 |
HUP0200244A3 (en) | 2003-05-28 |
CA2361885A1 (en) | 2000-10-12 |
BR0008577A (en) | 2002-10-01 |
CN1346273A (en) | 2002-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200201000A1 (en) | HORMONE-DESTINY THERAPY | |
IT1252868B (en) | ANTI-PHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE TO PREPARE IT AND ITS THERAPEUTIC USE | |
PT1079806E (en) | PREPARATIONS FOR THE APPLICATION OF ANTI-INFLAMMATORY, ESPECIALLY, ANTI-SEPTIC AGENTS AND / OR WOUND HEALING PROMOTION AGENTS, IN THE SUPERIOR AND / OR HEARING RESPIRATORY TRACT | |
BRPI0113286B8 (en) | substituted pyrazoles and pharmaceutical composition comprising the same. | |
EA200301022A1 (en) | HORMONAL REPLACEMENT THERAPY | |
SE0100158D0 (en) | Novel method and composition for local treatment of Meniere's disease and tinnitus | |
ATE451123T1 (en) | VAGINAL ADMINISTERED COMPOSITION FOR THE TREATMENT OF UTERINE DYSRHYTHMIA | |
KR950031060A (en) | Pharmaceutical composition for the treatment of osteoporosis | |
WO2001076638A3 (en) | Compositions for drug delivery | |
EE05259B1 (en) | Use of antiprogestins for the prophylaxis and treatment of hormone dependent diseases | |
ATE289293T1 (en) | SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE-STIMULATING HORMONE | |
ATE412412T1 (en) | DERIVATIVES OF 3-HYDROXY-4-(CYCLYL-ALKYLAMINOALKYL)-5-PHENYL-1-PYRAZOLE AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE (GNRH) FOR USE IN THE TREATMENT OF SEX HORMONAL DISEASES, SUCH AS PROSTATE OR MATERNAL CANCER | |
GB2368525A (en) | Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease | |
EA200301023A1 (en) | REPLACEMENT THERAPY WITH ESTROGENS | |
TW200501963A (en) | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases | |
EA200100828A1 (en) | 16 HYDROXYETTRATRIENES AS ESTROGENS OF ELECTORAL ACTION | |
ATE252910T1 (en) | METHOD OF TREATING FERTILITY DISORDERS | |
DK1343472T3 (en) | Thixotropic nasal spray | |
EA200100801A1 (en) | THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING | |
EA200200284A1 (en) | MESOPROGESTINES (PROGESTERONE RECEPTOR MODULATORS) AS A COMPONENT OF WOMEN'S CONTRACEPTIVES | |
EA200601089A1 (en) | TRANSDERMAL DELIVERY OF HORMONES WITHOUT THE NEED TO USE AGENTS, STRENGTHENING PENETRATION | |
BR0109279A (en) | Lhrh antagonists, their preparation and application as a medicine | |
EP0902025A3 (en) | Benzothiophenes for treatment of estrogen related conditions | |
ATE371737T1 (en) | PROTEAS RESISTANT FLINT ANALOGUE | |
MEP39708A (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine |